Compare SPWH & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPWH | MCRB |
|---|---|---|
| Founded | 1986 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.6M | 41.2M |
| IPO Year | 2014 | 2015 |
| Metric | SPWH | MCRB |
|---|---|---|
| Price | $1.16 | $1.41 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | $2.84 | ★ $17.00 |
| AVG Volume (30 Days) | ★ 247.9K | 82.3K |
| Earning Date | 12-03-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,209,182,000.00 | $789,000.00 |
| Revenue This Year | $0.99 | $1,648.67 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 0.96 | N/A |
| 52 Week Low | $1.03 | $1.30 |
| 52 Week High | $2.56 | $29.98 |
| Indicator | SPWH | MCRB |
|---|---|---|
| Relative Strength Index (RSI) | 54.51 | 23.16 |
| Support Level | $1.10 | N/A |
| Resistance Level | $1.21 | $2.26 |
| Average True Range (ATR) | 0.06 | 0.23 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 57.14 | 11.46 |
Sportsman's Warehouse Holdings Inc together with its subsidiaries operates as an outdoor sporting goods retailer. It provides a one-stop shopping experience that equips customers with the right quality, brand name hunting, shooting, fishing, and camping gear to maximize enjoyment of the outdoors. The company offers products in the categories of Camping, Apparel, Fishing, Footwear, Hunting and shooting, and Optics, Electronics, Accessories, and Other products. It provides products such as Backpacks, Jackets, Camp essentials, Hiking boots, GPS devices, ATV accessories and Fishing rods, among others. The company also offers an e-commerce experience, extensive in-store events and educational programming.
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.